| Autor: |
Gonchar, O. O., Karaban, I. M., Karasevich, N. V., Bratus, L. V., Mankovska, I. M. |
| Předmět: |
|
| Zdroj: |
Physiological Journal / Fiziologichnyi Zhurnal; 2022, Vol. 68 Issue 4, p20-27, 8p |
| Abstrakt: |
Effects of cerebrolysin (CBL) on prooxidant-antioxidant balance and oxidative stress (OS) developing in blood of patients with Parkinson's disease (PD) were studied. Twenty patients with PD and 10 healthy persons (control) participated in this study. Clinical diagnosis of PD was established according UK Brain Bank Criteria; the grades of PD were II-III after Hoehn/Yahr. PD patients received therapy with CBL administration intravenously at dose 20 ml (61.5 mg/kg) per day along 10 days. As OS biomarkers, lipid peroxidation (from the formation of thiobarbituric acid - reactive substances, TBARS), H2O2 production, the activities of SOD, catalase, and GPx, as well as glutathione pool indexes were measured in blood plasma and erythrocytes. It was established a significant rise in TBARS in plasma and H2O2 contents in erythrocytes from patients with PD compared to control. These events were accompanied by an increase in the SOD and catalase activities in plasma and a decrease in GSH content and GPx activity in erythrocytes. CBL administration counteracts the TBARS accumulation, reduces hyperactivation of SOD and catalase in plasma compared with the CBL-untreated patients. In erythrocytes of PD patients, CBL injection caused the limitation of H2O2 production as well as promotion the GSH pool recovery through an increase in GSH level and GPx activity. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
